Sundry Photography / Shutterstock.com
21 February 2020AmericasSarah Morgan
Illumina asks court to halt BGI’s sequencer distribution
Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
4 October 2019 A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
2 July 2019 Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Americas
18 June 2020 Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Editor's picks
Editor's picks
Big Pharma
4 October 2019 A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
2 July 2019 Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Americas
18 June 2020 Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Big Pharma
4 October 2019 A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
2 July 2019 Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Americas
18 June 2020 Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.